Trial Profile
XED-60 in the treatment of dry eye, Phase2 study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs XED 60 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Lion Corporation
- 14 Jun 2016 New trial record